Haematologica (Sep 2018)
A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma
- Paolo Strati,
- Dai Chihara,
- Yasuhiro Oki,
- Luis E Fayad,
- Nathan Fowler,
- Loretta Nastoupil,
- Jorge E Romaguera,
- Felipe Samaniego,
- Naveen Garg,
- Lei Feng,
- Emily T. Wesson,
- Charnelle E. Ruben,
- Mildred D. Stafford,
- Yago Nieto,
- Issa F Khouri,
- Chitra Hosing,
- Sandra B. Horowitz,
- Rammurti T-. Kamble,
- Michelle A. Fanale
Affiliations
- Paolo Strati
- Division of Cancer Medicine, MD Anderson Cancer Center, Houston, TX, USA
- Dai Chihara
- Department of Internal Medicine, University of New Mexico, Albuquerque, NM, USA
- Yasuhiro Oki
- Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA
- Luis E Fayad
- Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA
- Nathan Fowler
- Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA
- Loretta Nastoupil
- Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA
- Jorge E Romaguera
- Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA
- Felipe Samaniego
- Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA
- Naveen Garg
- Department of Diagnostic Radiology, MD Anderson Cancer Center, Houston, TX, USA
- Lei Feng
- Department of Biostatistics, MD Anderson Cancer Center, Houston, TX, USA
- Emily T. Wesson
- Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA
- Charnelle E. Ruben
- Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA
- Mildred D. Stafford
- Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA
- Yago Nieto
- Department of Stem Cell Transplantation, MD Anderson Cancer Center, Houston, TX, USA
- Issa F Khouri
- Department of Stem Cell Transplantation, MD Anderson Cancer Center, Houston, TX, USA
- Chitra Hosing
- Department of Stem Cell Transplantation, MD Anderson Cancer Center, Houston, TX, USA
- Sandra B. Horowitz
- Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA
- Rammurti T-. Kamble
- Department of Hematology-Oncology, Baylor College of Medicine and Houston Methodist Hospital, TX, USA
- Michelle A. Fanale
- Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA
- DOI
- https://doi.org/10.3324/haematol.2018.187617
- Journal volume & issue
-
Vol. 103,
no. 9
Abstract
No abstracts available.
